SEC Form 4 · accession 0001213900-17-002469
Actinium Pharmaceuticals, Inc. · ATNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sandesh Seth
Officer — Executive Chairman · Director
Period of report
Mar 14, 2017
Accepted (ET)
Mar 16, 2017 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388320
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to purchase common stock | $0.78 | Mar 14, 2017 | J | 64,746 | A | Jan 31, 2012 | Feb 11, 2022 | Common Stock | 65 | 64,746 | D |
| Warrant to purchase common stockF1 | $0.78 | Mar 14, 2017 | J | 99,619 | A | Jan 31, 2012 | Feb 11, 2022 | Common Stock | 99,619 | 100 | I |
| Warrant to purchase common stock | $2.34 | Mar 14, 2017 | J | 57,212 | D | Jan 19, 2012 | Jan 28, 2018 | Common Stock | 57,212 | 0 | D |
| Warrant to purchase common stock | $2.34 | Mar 14, 2017 | A | 57,212 | A | Mar 14, 2017 | Feb 11, 2022 | Common Stock | 57 | 57,212 | D |
| Options to purchase common stockF3 | $1.39 | Mar 14, 2017 | A | 750,000 | A | — | Mar 14, 2027 | Common Stock | 750,000 | 750,000 | D |
Explanation of responses
- F1Certain warrants were issued to Mr. Seth as part of investment banking and advisory services either prior to and outside of Mr. Seth's role as a Board Member and subsequently Executive Chairman and are not compensation for Board or Executive Chairman services to the Company. The Executive Chairman has refrained from exercising certain warrants that are or have been in the money for most of their term in order to align with the long term interests of the Company. In order to maintain that alignment on March 14. 2017, the warrant was amended to extend the term until February 11, 2022. The warrant issued for 99,619 shares was issued to Amrosan LLC, an entity affiliated with Mr. Seth's family.
- F2Certain warrants were issued to Mr. Seth as part of investment banking and advisory services either prior to and outside of Mr. Seth's role as a Board Member and subsequently Executive Chairman and are not compensation for these latter services to the Company. The Executive Chairman has refrained from exercising certain warrants that are or have been in the money for most of their term in order to align with the long term interests of the Company. In order to maintain that alignment on March 14, 2017 the Company cancelled a Warrant in the amount of 57,212, shares and issued a new warrant with a term until February 11, 2022.
- F3Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options shall vest each month from the date of grant. In addition, 100,000 options are subject to cancellation based on the obtainment of certain milestones.